Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Active Biotech on real estate transaction
Mandate

Vinge advises Active Biotech on real estate transaction

March 14, 2019 M&A

Active Biotech AB (publ) has entered an agreement regarding sale of the property Forskaren 1 in Lund, to an investor collective led by the real estate company Estea AB. The purchase price amounts to SEK 275 million. The transaction is subject to the general meeting’s approval. 

Vinge advises Active Biotech. Vinge’s team is primarily composed of Erik Sjöman, Anna Edström, Christian Lindhé and Jessica Salomonsson. 

Related

Vinge advises Stendörren in connection with issuance of green capital securities

 Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green capital securities in an amount of SEK 400 million (within a framework of SEK 800 million).
May 07, 2026

Vinge represents Cinven in connection with the acquisition of Ongoing Warehouse

 Vinge has represented the international private equity firm Cinven in connection with its acquisition of Ongoing Warehouse.
May 06, 2026

Vinge advises Fazer in connection with its acquisition of Aroma

 Fazer has entered into an agreement to acquire Konfektyrfabriken Aroma AB, a Swedish confectionery manufacturer known for its classic candy products such as Geléhallon, Hallonbåtar, Röda Hjärtan and Gräddkola. The acquisition strengthens Fazer's position in the Swedish confectionery market, particularly within pick & mix, packed candy, and seasonal products. The acquisition is subject to customary regulatory approvals.
May 06, 2026